Skip to main content
Premium Trial:

Request an Annual Quote

Greenwood Genetic Center to Offer Affymetrix's CytoScan Dx

NEW YORK (GenomeWeb) – Greenwood Genetic Center announced that it will offer Affymetrix's CytoScan Dx Assay chromosomal microarray analysis test, which scans a patient's genome for genetic causes of developmental delays, intellectual disabilities, and congenital abnormalities.

According to the Greenwood, SC-based center, it is the first US lab to offer the CytoScan Dx test.

The company received US Food and Drug Administration clearance early this year for the assay for use in pediatric constitutional cytogenetic testing. The test also has a CE-IVD mark allowing it to be sold for clinical use in Europe.

GGC said that it partnered with Affymetrix in clinical trials to demonstrate the assay's safety and effectiveness, and that it provided half of the 960 clinical samples used in the validation component of these studies. These studies found the CMA technology had improved ability to detect certain chromosomal abnormalities over standard chromosome testing and other commonly used tests, according to GGC.

The CytoScan Dx will be offered through the GGC Cytogenetics Laboratory, which currently analyzes approximately 1,500 CMA clinical samples per year.

"Two to three percent of children in the United States have some degree of intellectual disability and 1 in 33 newborns have a congenital anomaly," GGC Director Steve Skinner said in a statement. "Many of these are associated with genetic changes, and for these families, finding a diagnosis with the traditional tests can be a journey that, if ever realized, may take months or even years. This new test accelerates the diagnosis, and opens up more possibilities for better understanding of these conditions allowing us to move closer toward effective treatments," Skinner said.

As reported by BioArray News earlier this month, Affymetrix CEO Frank Witney said during the firm's second quarter earnings call that the company is working with consultants and payers to optimize reimbursement for the test.

The Scan

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.

Analysis of Endogenous Parvoviral Elements Found Within Animal Genomes

Researchers at PLOS Biology have examined the coevolution of endogenous parvoviral elements and animal genomes to gain insight into using the viruses as gene therapy vectors.

Saliva Testing Can Reveal Mosaic CNVs Important in Intellectual Disability

An Australian team has compared the yield of chromosomal microarray testing of both blood and saliva samples for syndromic intellectual disability in the European Journal of Human Genetics.

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.